These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 25971624)

  • 21. Risk for malignancies of infectious etiology among adult survivors of specific non-Hodgkin lymphoma subtypes.
    Herr MM; Schonfeld SJ; Dores GM; Engels EA; Tucker MA; Curtis RE; Morton LM
    Blood Adv; 2019 Jul; 3(13):1961-1969. PubMed ID: 31262739
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Secondary primary malignancy risk among patients with esophageal cancer in Taiwan: a nationwide population-based study.
    Chen SC; Teng CJ; Hu YW; Yeh CM; Hung MH; Hu LY; Ku FC; Tzeng CH; Chiou TJ; Chen TJ; Liu CJ
    PLoS One; 2015; 10(1):e0116384. PubMed ID: 25635388
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Age-time risk patterns of solid cancers in 60 901 non-Hodgkin lymphoma survivors from Finland, Norway and Sweden.
    Lorenzo Bermejo J; Pukkala E; Johannesen TB; Sundquist J; Hemminki K
    Br J Haematol; 2014 Mar; 164(5):675-83. PubMed ID: 24528128
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts.
    Huang KP; Weinstock MA; Clarke CA; McMillan A; Hoppe RT; Kim YH
    Arch Dermatol; 2007 Jan; 143(1):45-50. PubMed ID: 17224541
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapeutic radiation for lymphoma and risk of second primary malignant mesothelioma.
    Chang ET; Lau EC; Mowat FS; Teta MJ
    Cancer Causes Control; 2017 Sep; 28(9):971-979. PubMed ID: 28755241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Second Primary Malignant Neoplasms and Survival in Adolescent and Young Adult Cancer Survivors.
    Keegan THM; Bleyer A; Rosenberg AS; Li Q; Goldfarb M
    JAMA Oncol; 2017 Nov; 3(11):1554-1557. PubMed ID: 28426850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Increased incidence of malignant melanoma and other rare cutaneous cancers in the setting of chronic lymphocytic leukemia.
    Brewer JD; Shanafelt TD; Call TG; Cerhan JR; Roenigk RK; Weaver AL; Otley CC
    Int J Dermatol; 2015 Aug; 54(8):e287-93. PubMed ID: 25772131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Second primary malignancy risk after radiotherapy in rectal cancer survivors.
    Wang TH; Liu CJ; Chao TF; Chen TJ; Hu YW
    World J Gastroenterol; 2018 Oct; 24(40):4586-4595. PubMed ID: 30386108
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Risk Factors for Melanoma Among Survivors of Non-Hodgkin Lymphoma.
    Lam CJ; Curtis RE; Dores GM; Engels EA; Caporaso NE; Polliack A; Warren JL; Young HA; Levine PH; Elmi AF; Fraumeni JF; Tucker MA; Morton LM
    J Clin Oncol; 2015 Oct; 33(28):3096-104. PubMed ID: 26240221
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Risk of Second Primary Malignancies in Lung Cancer Survivors - The Influence of Different Treatments.
    Su VY; Liu CJ; Chen YM; Chou TY; Chen TJ; Yen SH; Chiou TJ; Liu JH; Hu YW
    Target Oncol; 2017 Apr; 12(2):219-227. PubMed ID: 27766477
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis B virus infection and risk of intrahepatic cholangiocarcinoma and non-Hodgkin lymphoma: a cohort study of parous women in Taiwan.
    Fwu CW; Chien YC; You SL; Nelson KE; Kirk GD; Kuo HS; Feinleib M; Chen CJ
    Hepatology; 2011 Apr; 53(4):1217-25. PubMed ID: 21480326
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased incidence of second primary malignancy in patients with malignant astrocytoma: a population-based study.
    Wang W
    Biosci Rep; 2019 Jun; 39(6):. PubMed ID: 31138756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Secondary Solid Organ Neoplasm in Patients with Acute Lymphoblastic Leukemia: A Nationwide Population-Based Study in Taiwan.
    Teng CJ; Huon LK; Hu YW; Yeh CM; Chien SH; Chen SC; Liu CJ
    PLoS One; 2016; 11(4):e0152909. PubMed ID: 27035574
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Risk of second primary malignancies among 1537 melanoma patients and risk of second primary melanoma among 52 354 cancer patients in Northern Italy.
    Caini S; Radice D; Tosti G; Spadola G; Cocorocchio E; Ferrucci PF; Testori A; Pennacchioli E; Fargnoli MC; Palli D; Bazolli B; Botteri E; Gandini S
    J Eur Acad Dermatol Venereol; 2016 Sep; 30(9):1491-6. PubMed ID: 26990937
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma.
    Tward JD; Wendland MM; Shrieve DC; Szabo A; Gaffney DK
    Cancer; 2006 Jul; 107(1):108-15. PubMed ID: 16708354
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Risk of second primary malignancies following cutaneous melanoma diagnosis: a population-based study.
    Spanogle JP; Clarke CA; Aroner S; Swetter SM
    J Am Acad Dermatol; 2010 May; 62(5):757-67. PubMed ID: 20223559
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Lifetime risks of second primary malignancies after pediatric Hodgkin lymphoma and non-Hodgkin lymphoma.
    Wang L; Zheng Y; Luo R; Kang K; Niedermann G; Zhao A; Wu Y
    J Cancer Res Clin Oncol; 2024 Jan; 150(2):41. PubMed ID: 38280006
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increasing Incidence of B-Cell Non-Hodgkin Lymphoma and Occurrence of Second Primary Malignancies in South Korea: 10-Year Follow-up Using the Korean National Health Information Database.
    Kim JS; Liu Y; Ha KH; Qiu H; Rothwell LA; Kim HC
    Cancer Res Treat; 2020 Oct; 52(4):1262-1272. PubMed ID: 32599988
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.